| Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664) |
|---|
| 05/06/2008 | US7368568 Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for production and the use |
| 05/06/2008 | US7368415 Substituted beta-(oxazolidin-3-ylcarbonyl)styrenes: 1-[2-(2,4-Dimethyl-cyclohex-3-enyl)-oxazolidin-3-yl]-3-(2-hydroxy-phenyl)-propenone; for delivering fragrances to a laundary detergent, shampoo or hair conditioner |
| 05/02/2008 | WO2008050858A1 Amide compound, salt thereof, and biofilm remover using them |
| 05/02/2008 | WO2008049808A1 Mtp inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives |
| 05/02/2008 | WO2008049729A1 Non-steroidal brassinosteroid mimetic |
| 05/02/2008 | CA2666124A1 Non-steroidal brassinosteroid mimetic |
| 05/02/2008 | CA2664143A1 Mtp inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives |
| 05/02/2008 | CA2631024A1 Anthranilic acid derivatives useful in treating infection with hepatitis c virus |
| 04/30/2008 | EP1915357A1 2-hydroxy-propionic acid derivatives and 3-hydroxy-benzofuran-2-one derivatives with affinity for the gaba-b-receptor |
| 04/30/2008 | EP1915340A2 Synthetic processes for the preparation of aminocyclohexyl ether compounds |
| 04/30/2008 | EP1915328A1 Continuous crystallisation process of iodinated phenyl derivatives |
| 04/30/2008 | CN100384815C Fungicides |
| 04/29/2008 | CA2336474C C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/29/2008 | CA2254833C Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 04/24/2008 | WO2008001166A3 Process for synthesis of glycomimicking cationic amphiphiles |
| 04/24/2008 | US20080096970 Stable Nateglinide Form B Compositions |
| 04/24/2008 | US20080096869 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/23/2008 | EP1007033B1 Lymphocyte function antigen-1 antagonists |
| 04/22/2008 | US7361783 Agonists for human PPAR alpha isoform; exhibit lipid-lowering effect, inhibitory effect on the arteriosclerosis, antiobesity effect, blood glucose-lowering effect; 2-{[3-(N-{[4-(3,5-bistrifluoromethylphenoxy)phenyl]methyl}carbamoyl)-4-methoxyphenyl]methyl}butyric acid |
| 04/22/2008 | CA2354619C Intermediates and process for producing fluorine-containing amino acid compound by using the same |
| 04/17/2008 | WO2008044033A1 Amide derivatives |
| 04/17/2008 | WO2007115836A3 Tetrahydronaphtol-derivatives and use thereof |
| 04/17/2008 | US20080091031 Ortho-substituted pentafluorosulfanylbenzenes, process for their preparation and their use as valuable synthetic intermediates |
| 04/17/2008 | US20080090959 Epoxide polymer surfaces |
| 04/17/2008 | US20080090854 Cxcr2 inhibitors |
| 04/16/2008 | EP1744742A4 Crystalline and amorphous forms of efaproxiral sodium |
| 04/16/2008 | EP1581471B1 Cyclopentenone derivatives for cancer therapy |
| 04/16/2008 | EP1414787B1 New derivatives of substituted anilines with herbicidal activity |
| 04/16/2008 | CN101163665A Alpha, omega-difuctional aldaramides |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/15/2008 | US7358396 can be resolved using optically active carboxylic acids or enzymes; compounds such as 1-benzyloxy-3-aminobutane |
| 04/15/2008 | US7358383 Polyphenol proteasome inhibitors, synthesis, and methods of use |
| 04/15/2008 | CA2211981C Production of enantiomerically enriched ortho-substituted .alpha.,.alpha.-diaromatic methanols |
| 04/10/2008 | WO2008013993A3 Processes for the synthesis of o-desmethylvenlafaxine |
| 04/10/2008 | WO2007144652A3 Parp inhibitors |
| 04/10/2008 | US20080085994 T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| 04/09/2008 | EP1299348B1 Compounds and compositions for delivering active agents |
| 04/09/2008 | CN101160282A Acetylene derivatives |
| 04/09/2008 | CN101157628A Substituted benzoic acid nitrogen-containing derivatives and antineoplastic usage thereof |
| 04/09/2008 | CN101156840A Inhibitors of oleamide hydrolase |
| 04/09/2008 | CN100379729C Nitro compounds and their application in preparation of pemetrexed |
| 04/09/2008 | CN100379720C Closed polyisocyanic acid ester |
| 04/08/2008 | US7355079 Thyronamine derivatives and analogs and methods of use thereof |
| 04/08/2008 | US7355069 2-[2-(4-{2-[ethyl(2-fluorobenzyl)amino]-2-oxoethoxy}phenyl)ethoxy]benzoic acid; peroxisome proliferator-activated receptors alfa agonist; antidiabetic, hypotensive agent; obesity, elevated VLDL (Very Low Density Lipoproteins) and reduced HDL (High Density Lipoprotein) concentrations |
| 04/03/2008 | US20080081927 Crystal forms of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine |
| 04/03/2008 | DE102004011720B4 Radiohalogenierte Benzamidderivate und deren Verwendung in der Tumordiagnostik und Tumortherapie Radio Halogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy |
| 04/02/2008 | EP1905757A1 Derivatives of Venlafaxine and methods of preparing and using the same |
| 04/02/2008 | EP1904436A1 Modified poly(propylene-imine) dendrimers and their use as transfection agents for anionic bioactive factors |
| 04/02/2008 | EP1904435A2 Benzamide derivatives and uses related thereto |
| 04/02/2008 | CN100378063C Novel compounds and medicinal use thereof |
| 04/01/2008 | US7351861 Halo-substituted N-arylanilides with one or more hydroxy groups that may be esterified; N-benzilideneiminoarylamides; antibacterial agents |
| 04/01/2008 | US7351858 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 04/01/2008 | US7351852 T-butoxycarbonylaminoethylamine for the synthesis of PNA monomer units, amino acid derivatives, intermediates therof, and processes for productions of them |
| 04/01/2008 | US7351741 4-(4-chloro2-hydroxybenzoylamino)butyric acid or salts for delivering an agent that would otherwise be destroyed or rendered less effective by conditions encountered before the agent reaches its target zone |
| 04/01/2008 | US7351719 Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds |
| 03/27/2008 | WO2008013990A3 Processes for the synthesis of o-desmethylvenlafaxine |
| 03/27/2008 | US20080076769 Norvaline Derivative and Method for Preparation Thereof |
| 03/26/2008 | EP1462439B1 Novel stable crystals of substituted phenylpropionic acid derivative and process for producing the same |
| 03/26/2008 | CN101151239A Novel biaromatic compounds, inhibitors of the P2X7-receptor |
| 03/26/2008 | CN101148418A Alpine yarrow herb ketoacid derivatives and applications thereof |
| 03/26/2008 | CN100376546C Diethyl 4(4-oxobutyl) benzoyl-L-glutamate and its preparation and use |
| 03/25/2008 | US7348457 N-[9-hydroxy-10-oxo-12(Z),15(Z)-eicosadienoyl]-L-isoleucine; for providing flower bud promoting activity, stress-resistance, antiaging activity to the plants |
| 03/25/2008 | US7348449 Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof |
| 03/20/2008 | WO2008032156A1 Diaryl ether derivatives and uses thereof |
| 03/20/2008 | WO2008031508A1 TARTRATE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS |
| 03/20/2008 | US20080070869 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 03/20/2008 | CA2663543A1 Tartrate derivatives for use as coagulation factor ixa inhibitors |
| 03/19/2008 | EP1900759A2 Polymer production |
| 03/19/2008 | EP1900364A2 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 03/19/2008 | EP1898899A1 Inhibitors of fibroblast activation protein alpha |
| 03/19/2008 | CN101143834A Polymorphism for N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide sodium salt and preparation method thereof |
| 03/18/2008 | US7344868 Amide formation and esterification performed by lipases, between fatty acids and/or esters of fatty acids and amino-alcohols; used in the form of cosmetic and/or dermatology |
| 03/13/2008 | WO2008028859A1 A process for the manufacture of snac (salcaprozate sodium) |
| 03/13/2008 | US20080064731 Remedy for chronic disease |
| 03/13/2008 | US20080064693 N-2 Adamantanyl-2-Phenoxy-Acetamide Derivatives as 11-Beta Hydroxysteroid Dehydrogenase Inhibitors |
| 03/12/2008 | EP1896396A1 Anthranilic acid derivatives |
| 03/12/2008 | EP1567480B1 N-alkynyl-2-(substituted phenoxy) alkylamides and their use as fungicides |
| 03/12/2008 | CN101142175A Peptidic compounds |
| 03/12/2008 | CN101139306A Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter |
| 03/12/2008 | CN101139304A Conjugated dienamides and uses thereof |
| 03/12/2008 | CN100374423C Process for the preparation of 4-methyl-7-aminoquinolones |
| 03/11/2008 | US7342131 Levodopa prodrugs, and compositions and uses thereof |
| 03/11/2008 | US7342038 Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation |
| 03/11/2008 | CA2192764C Integrin receptor antagonists |
| 03/06/2008 | WO2008025694A1 Inhibitors for glyt-1 |
| 03/06/2008 | WO2007145835A3 Benzamide derivatives as modulators of 11beta-hsd1 for treating diabetes and obesity |
| 03/06/2008 | US20080058377 N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-2-yl)-N'-[4-(trifluoromethyl)benzyl] urea; antiinflammatory agent: asthma or COPD, analgesic: neuralgia, neuropathies, algesia, nerve injury, ischemia, neurodegeneration, or stroke; urological diseases: urinary incontinence or overactive bladder |
| 03/06/2008 | US20080058314 Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/06/2008 | US20080058290 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders |
| 03/06/2008 | CA2661863A1 Inhibitors for glyt-1 |
| 03/05/2008 | EP1894569A2 Tetracycline derivatives for treating cancer |
| 03/05/2008 | EP1893562A1 Reversible inhibitors of monoamine oxidase a and b |
| 03/05/2008 | EP1368020B1 Method for identifying maxi-k channel blockers |
| 03/05/2008 | CN101137650A 2-[(isoquinolin-3-carbonyl)amino]-propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis |
| 03/05/2008 | CN101137636A Exo-selective synthesis of himbacine analogs |
| 03/05/2008 | CN101137616A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 03/05/2008 | CN101134732A New method for preparing 2-{4-[[(3,5-dimethylaniline)carbonyl ]methyl]phenoxy}-2-methyl sodium propionate and its crystal in water |
| 03/05/2008 | CN101134726A Derivant of salviol acidn A and its application as antioxidant |
| 02/27/2008 | EP1891026A2 Cycloalkylidene compounds as selective estrogen receptor modulators |
| 02/27/2008 | EP1890690A2 Mao-b inhibitors useful for treating abesity |